amylum

Also found in: Dictionary, Thesaurus, Encyclopedia.

starch

(starch),

A high molecular weight polysaccharide made up of d-glucose residues consisting of 20% amylose and 80% amylopectin. amylose contains α-1,4 linkages, differing from cellulose in the presence of α- rather than β-glucoside linkages, and amylopectin contains additional α-1,6 linkages; both amylose and amylopectin exist in most most plant tissues. Starch is converted into dextrin when subject to the action of dry heat, and into dextrin and d-glucose by amylases and glucoamylases in saliva and pancreatic juice; used as a dusting powder, an emollient, and an ingredient in medicinal tablets; is an important raw material for the manufacture of alcohol, acetone, n-butanol, lactic acid, citric acid, glycerine, and gluconic acid by fermentation; is the chief storage carbohydrate in most higher plants.

Synonym(s): amylum

[A.S. stearc, strong]

Farlex Partner Medical Dictionary © Farlex 2012

amylum

Starch.

Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

starch

(stahrch)

High molecular weight polysaccharide made up of d-glucose residues consisting of 20% amylose and 80% amylopectin.
Synonym(s): amylum.

[A.S. stearc, strong]

Medical Dictionary for the Dental Professions © Farlex 2012

Mentioned in ?

References in periodicals archive ?

Tate & Lyle said: "We anticipate results will be close to market expectations with a weaker Amylum result in the final quarter being offset by a satisfactory performance in the rest of the business."

Tate & Lyle warns of crop prices squeeze on profits

In Europe, performance improved with profits pounds 12m higher with Amylum reporting higher profits and robust revenues from by-products.

Sweet and sour news as Tate & Lyle reports lower profit but raised dividend

In Europe, small pricing gains for certain products made by the Amylum starch operation had been offset by price reductions elsewhere.

Tate & Lyle disappoints investors

Tate & Lyle, tel:020 7626 6525, whilst continuing to refocus the Group towards higher-margin and higher-growth businesses, disposing of underperforming assets and eliminating costs wherever possible, have acquired the minorities in Amylum and Staley; as well as selling off the commodity Australian sugar business, at Bundaberg, and eight of the company's other smaller businesses.

Tate & Lyle's Interim Report

Only a small quantity of amylum and protein can be decomposed to monosaccharide and free amino acid.

Effects of enzyme supplementation on growth, intestinal content viscosity, and digestive enzyme activities in growing pigs fed rough ricebased diet *

Trading benefited from better performances by the cereal sweetener business Staley and European starch company Amylum.

Tate & Lyle sweetens the bottom line

Tate and Lyle, tel:020 7626 6525, have reached an agreement with Compagnie Industrielle et Fianci[grave{e}]re des Produits Amylaces SA to acquire, for a total consideration of [pounds]274m., the minority interests held by CIP in Amylum (36.7%) and Staley (l0%), Tate and Lyle's European and US starch subsidiaries.

Tate and Lyle's Proposed Acquisition

Tate & Lyle is buying up the minority stakes it does not already own in Amylum, a cereal sweetener and starches business in Europe, and in Staley, a US corn starch business.

Sweet life in US is looking increasing sour for Tate & Lyle as sugar prices fall

Its North American starch business Staley, and European starch company Amylum, improved performance, benefiting from better margins.

Tate & Lyle bounces back into profit

Its majority owned Amylum starch operation in Europe continued to make good progress.

Bitter taste for Tate & Lyle investors as earnings forecast is cut back

In Europe Amylum's wheat starch plant in Bordeaux, France was closed in June 1999.

Tate & Lyle's Developments

In Europe Amylum, the group's cereal sweetener and starch business, saw lower profits as prices came under pressure.